Home/Filings/4/0001209191-20-043737
4//SEC Filing

Puissance Capital Management (GP) LLC 4

Accession 0001209191-20-043737

CIK 0001549084other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 4:42 PM ET

Size

13.5 KB

Accession

0001209191-20-043737

Insider Transaction Report

Form 4
Period: 2020-07-23
Transactions
  • Award

    Common Stock

    2020-07-23+7,3839,958 total
Holdings
  • Common Stock

    (indirect: By LLC)
    774,400
Transactions
  • Award

    Common Stock

    2020-07-23+7,3839,958 total
Holdings
  • Common Stock

    (indirect: By LLC)
    774,400
Wang Theodore T
Director10% Owner
Transactions
  • Award

    Common Stock

    2020-07-23+7,3839,958 total
Holdings
  • Common Stock

    (indirect: By LLC)
    774,400
Transactions
  • Award

    Common Stock

    2020-07-23+7,3839,958 total
Holdings
  • Common Stock

    (indirect: By LLC)
    774,400
Transactions
  • Award

    Common Stock

    2020-07-23+7,3839,958 total
Holdings
  • Common Stock

    (indirect: By LLC)
    774,400
Footnotes (3)
  • [F1]The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021.
  • [F2]After taking into account the 1-for-15 reverse stock split effective March 24, 2020.
  • [F3]These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Issuer

EKSO BIONICS HOLDINGS, INC.

CIK 0001549084

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001695339

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:42 PM ET
Size
13.5 KB